RedPath Integrated Pathology's Unattributed VC - II Round

RedPath Integrated Pathology raised a round of funding on August 18, 2006. Investors include Pittsburgh Life Sciences Greenhouse.

RedPath Integrated Pathology is a genomics-based molecular diagnostics company that provides cancer diagnostic testing for pathologists, oncologists and clinicians. The company's CLIA licensed, CAP ce…

Articles about RedPath Integrated Pathology's Unattributed VC - II Round: